Patent ID: 11883382
Assignee: SOMERSET THERAPEUTICS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. The composition of claim 1, wherein the effective amount of the one or more chelating agents (1) detectably or significantly improves the stability of the ketorolac tromethamine, the phenylephrine hydrochloride, or both the ketorolac tromethamine and the phenylephrine hydrochloride, (2) detectably or significantly enhances the effectiveness of any one or more preservatives in the composition, or (3) both (a) detectably or significantly improves the stability of the ketorolac tromethamine, the phenylephrine hydrochloride, or both the ketorolac tromethamine and the phenylephrine hydrochloride and (b) detectably or significantly enhances the effectiveness of any one or more preservatives in the composition, when the composition is stored under storage conditions for a storage period of at least about 2 weeks, wherein storage conditions comprise storage at 25° C.+/−2° C., at about 25° C. and about 60% relative humidity, storage at about 40° C. and about 75% relative humidity, or any combination of such conditions.